Skip to main content
Clinical Trials/IRCT20210823052264N1
IRCT20210823052264N1RecruitingPhase 3

To Compare the efficacy of Transamic acid (TA) mesotherapy vs Hydroquinone, Flucinolone acetonide and Tretinoin for melasma

PNS SHIFA0 sites70 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Sponsor
Enrollment
70

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 55 years (—)
Sex
All

Inclusion Criteria

  • Males and females 18-55 years with facial melasma

Exclusion Criteria

  • Patients who has bleeding disorders, pregnant women and lactating mothers.

Investigators

Sponsor
PNS SHIFA

Similar Trials